HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loretta Jacques Selected Research

Therapeutics

1/2018Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
11/2017Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.
11/2016Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
12/2015Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials.
1/2015Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.
8/2014Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
7/2014Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
6/2014Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids.
4/2014Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.
3/2014Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Loretta Jacques Research Topics

Disease

41Asthma (Bronchial Asthma)
01/2020 - 03/2006
9Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 01/2012
2Oral Candidiasis (Thrush)
11/2012 - 01/2012
1Tremor (Tremors)
09/2012

Drug/Important Bio-Agent (IBA)

31fluticasone furoateFDA Link
01/2020 - 10/2011
27Adrenal Cortex Hormones (Corticosteroids)IBA
08/2019 - 03/2006
26vilanterolIBA
01/2020 - 01/2012
13Fluticasone (Cutivate)FDA LinkGeneric
01/2020 - 03/2006
5Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
01/2019 - 03/2006
4Salmeterol Xinafoate (Serevent)FDA Link
06/2014 - 01/2008
3Hydrocortisone (Cortisol)FDA LinkGeneric
10/2013 - 01/2012
2Albuterol (Salbutamol)FDA LinkGeneric
01/2019 - 03/2006
2Bronchodilator Agents (Bronchodilators)IBA
12/2011 - 01/2008
1Budesonide (Pulmicort)FDA LinkGeneric
01/2018
1Formoterol Fumarate (Oxis)FDA Link
01/2018
1Capsules (Microcapsules)IBA
10/2013
1Prednisolone (Predate)FDA LinkGeneric
10/2013
1Glucose (Dextrose)FDA LinkGeneric
09/2012
1PotassiumIBA
09/2012

Therapy/Procedure

16Therapeutics
01/2018 - 01/2008
4Dry Powder Inhalers
06/2014 - 01/2012
3Nebulizers and Vaporizers (Inhaler)
01/2019 - 03/2006